The Latest Cardiac and Vascular News
MINNEAPOLIS, June 10, 2021 (GLOBE NEWSWIRE) — CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced the completion of the first clinical procedure with the company’s new lead implantation approach. The novel ultrasound-guided technique is the latest advancement of CVRx’s Barostim™ Baroreflex Activation […]
2021-06-10 PRESSRELEASE Arcoma receives first order on the new product, OMNERA 500A Arcoma AB has received the first order on the new product OMNERA 500A. The OMNERA 500A is a new X-ray system developed with focus on efficient workflow, safety and ease of use. The ergonomic design simplifies and optimizes […]
A dual-center study from UCSD Health and Mills-Peninsula Sutter Health concluded that a simplified, non-invasive radio-ablation workflow, involving vMap™, was Feasible, Efficient, and Precise CARLSBAD, Calif.–(BUSINESS WIRE)–Vektor Medical, Inc. announced that a dual-center study reports that vMap™, as part of a new, non-invasive workflow, improved efficiency and precision for radio-ablation therapy […]
Advanced intelligent Clear-IQ Engine (AiCE) for PET will be introduced at SNMMI 2021 on Cartesion Prime , Further Expanding the Technology Across Modalities and into Molecular Imaging TUSTIN, Calif.–(BUSINESS WIRE)–Bringing the power of artificial intelligence (AI) to molecular imaging, Advanced intelligent Clear-IQ Engine (AiCE), Canon Medical Systems USA Inc.’s Deep Learning […]
A novel single-use, bioactive sternal plating system for use after open heart surgery. MARQUETTE, Mich.–(BUSINESS WIRE)–Able Medical Devices announces the recent launch of its Valkyrie™ Thoracic Fixation System, the market’s first single-use radiolucent plating system designed to span the osteotomy and close the sternum after open heart surgery. The system’s […]
One-of-a-kind diagnostic blood test identifies asymptomatic at-risk patients missed by the current standard of care IRVINE, Calif., June 9, 2021 /PRNewswire/ — Predictive Health Diagnostics Company, Inc. (“PHDC” or “the Company”), a diagnostics development platform company that develops, manufactures, and distributes specialty diagnostic tests combining science, technology, and proprietary analytics to detect diseases with significant unmet medical needs, today announced […]
New Procedures Include Open Heart Surgery, Minimally Invasive Surgical Approaches for Atrial Fibrillation and Heart Valves, and Lung Cancer Operations GLENWOOD SPRINGS, Colo., June 9, 2021 /PRNewswire/ — The Heart & Vascular Center at Valley View is pleased to introduce new services to continue to provide patients with world-class, convenient and compassionate care on […]
Positive Data from Completed InRhythm Phase 2 Study Demonstrate Safe and Rapid Conversions from Atrial Fibrillation to Normal Sinus Rhythm Plans to Initiate RESTORE1: Single Pivotal Phase 3 Trial in Atrial Fibrillation in Q3 2021; Data Expected 2H 2022 Appointment of Angela Wang as CFO Strengthens Management Team and Supports […]
GHENT, Belgium, June 09, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA, the “Company” or “Sequana Medical”), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, today announces that the abstract on the results from its RED DESERT alfapump DSR (Direct Sodium […]
Successfully Completes Initial Batch Production of JAN101, Demonstrating CGMP-scale Production Capabilities LAS VEGAS, June 8, 2021 /PRNewswire/ — JanOne Inc. (Nasdaq: JAN), a company focused on developing treatments for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, today announced the successful completion of Current Good Manufacturing Practices (CGMP) production of […]
